Henrietta Lacks

Henrietta Lacks built a legacy in modern medicine through the living tissue of her own body: the cervical cancer cells doctors took from her in 1951 without consent, which became the HeLa cell line that powered breakthroughs in polio vaccines, cancer therapies, virology, and biotechnology for decades. Her cells became a foundational tool of biomedical science, even as the official record treated her first as a patient, then as an anonymous cell source, and only belatedly as a Black woman whose story and family deserved recognition. In February 1951, at Johns Hopkins Hospital in Baltimore, Lacks was treated for aggressive cervical cancer. During a biopsy, physician‑researcher George Gey’s lab kept fragments of her tumor and found that the cells not only survived outside the body but multiplied rapidly and continuously. Those “HeLa” cells—named by splicing the first two letters of her first and last name—became the first widely used immortal human cell line, shipped worldwide and used in experiments without the knowledge of Lacks or her family.

1.What her cells built

HeLa cells derived from Henrietta Lacks’s tumor became the workhorses of postwar biomedical research. Their ability to divide indefinitely under laboratory conditions allowed scientists to run standardized experiments across time and institutions, something impossible with short‑lived cell cultures. HeLa cultures were used to test the Salk polio vaccine’s effectiveness, accelerating one of the twentieth century’s landmark public health achievements.

Over subsequent decades, HeLa cells played key roles in cancer biology, virology, toxicology, and genetics. Researchers used them to study how viruses infect cells, how radiation and drugs affect human tissue, and how chromosomes behave. HeLa cells were among the first human cells to be cloned, sent into space to observe the effects of zero gravity on cell growth, and incorporated into countless commercial kits and products used by labs around the world. All of this scientific and economic infrastructure rests on a cell line that originates in Lacks’s body.

2.The taking of the tissue

Henrietta Lacks sought care at Johns Hopkins because it was one of the few hospitals in Baltimore that treated Black patients. In 1951, standard practice allowed physicians to collect and use patient tissue samples for research without explicit consent, particularly in charity wards where Black and poor patients were concentrated. During her treatment, pieces of Lacks’s tumor were passed to Gey’s lab, which found the cells unusually robust and began distributing them to other scientists.

Lacks herself was not told that her tissue was being used in this way, nor that her cells had unique properties. She died in October 1951, unaware that parts of her body would continue living in laboratories for generations. The absence of consent was not an aberration but a reflection of a medical culture that treated Black patients’ bodies as available material, a pattern also visible in contemporaneous cases such as the Tuskegee syphilis study.

3.Erasure and misattribution in the official story

For years after HeLa’s spread, Henrietta Lacks’s name was actively obscured. Scientific papers referred to the cells simply as “HeLa,” and when her identity was discussed at all, it was sometimes misreported as “Helen Lane” or “Helen Larson,” distancing the line from a real Black woman and her family. This anonymity allowed HeLa to become a neutral scientific resource in the public imagination, while the origin’s racial and ethical dimensions remained buried.

The cells themselves were treated as a creation of laboratory science, with credit accruing to researchers who grew, shipped, and experimented on them, rather than to the person whose biology made their immortality possible. That framing fits a broader pattern in which Black and poor patients are sources of samples but not seen as authors of the research that depends on those samples.

4.The Lacks family’s fight for recognition and control

Henrietta Lacks’s descendants did not learn the full extent of HeLa’s use until the 1970s, when scientists contacted them for blood samples to help interpret HeLa’s unusual genetics. Even then, they were not offered compensation or control, only fragmented information. It was not until the early 2000s, through the work of journalist Rebecca Skloot and others, that Lacks’s story gained widespread public attention and the family began to assert narrative ownership.

In 2013, after HeLa’s full genome sequence was posted online without their consent, the Lacks family reached an agreement with the U.S. National Institutes of Health granting them a role in approving access to certain genomic data. More recently, they have pursued legal actions against companies profiting from HeLa, arguing that her cells’ commercial exploitation without consent violates her rights and theirs. These efforts refract her cellular legacy through contemporary struggles for reparative justice, data sovereignty, and respect for Black bodily autonomy.

5.Why the archive names her as an author

The scientific record often frames Henrietta Lacks as a patient whose cells happened to be useful, with real authorship attributed to the researchers who cultured and applied them. The archive rejects that hierarchy. Without Lacks’s particular biology, HeLa would not exist; without HeLa, vast swaths of biomedical progress would have been slower or taken different paths. Her body is not incidental to this story—it is central.

Naming Lacks as an author does not diminish the work of scientists; it corrects the erasure of the person whose tissue enabled their work. Her case also exposes how research structures systematically minimize the contributions and rights of Black participants. By restoring her name, biography, and family to the narrative of HeLa, we insist that scientific tools have human origins and that Black women’s bodies have been both engines of progress and sites of exploitation.

The family archive is admissible here. Photographs, letters, deeds, church programs, funeral bulletins, business records, recordings — the things that were kept when no institution was keeping them. A keeper reviews everything before it is admitted, and your name stays on it.

7.References